LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Avalyn Pharma Inc.
Headquarters:
Seattle, WA, United States
Website:
https://www.avalynpharma.com...
Year Founded:
2011
Status:
Private
BioCentury
|
Apr 26, 2024
Finance
Venture report: Arch, Foresite $1B AI play Xaira starting with Baker lab’s de novo biologics
Plus rounds for Rubedo, Flindr, Endeavor, SynOx and more
Read More
BioCentury
|
Dec 16, 2023
Management Tracks
Mistras, Martin join Viatris
Plus: Nassim Usman at the helm at Totus as it raises $66M series B round, and updates from Tourmaline, HKEX, CIRM, CorMedix and RiverVest
Read More
BioCentury
|
Nov 7, 2023
Management Tracks
Krishnan promoted to president and head of R&D at OncoNano
Plus: McCourt becomes co-CEO of Hudson, and updates from MeMed, Enhance3D and Avalyn
Read More
BioCentury
|
Sep 28, 2023
Deals
Sept. 27 Quick Takes: Roche and Ionis taking another approach to Huntington disease
Plus: Venture financings for Avalyn, Sitryx and Singaporean newco Automera and updates from Biohaven, Ginkgo, Pfizer, Gilead and Gracell
Read More
BioCentury
|
Aug 7, 2023
Management Tracks
Khoo Shih named CEO of Singapore’s ClavystBio
Plus: New CEOs named at Vivoryon and Kytopen, and updates from Avalyn, Ankyra, Indaptus and more
Read More
BioCentury
|
Oct 17, 2022
Management Tracks
Baranowski becomes CEO at Avalyn
Plus new CMO at Ankyra as Kaufman becomes CEO, and updates from Verge, Zentalis, Aviceda and more
Read More
BioCentury
|
Oct 21, 2021
Management Tracks
Dana-Farber’s David Livingston dies at 80
Plus: Alzheimer's Association, Aerie, Elevation, BioPorto, Opus and more
Read More
BioCentury
|
Apr 28, 2020
Finance
April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic
Read More
BioCentury
|
May 19, 2017
Finance
Breathe in, cash out
How a new CEO and a big series A could take Genoa to value inflection
Read More
BioCentury
|
May 17, 2017
Financial News
Genoa's series A brings in $62M
Read More
Items per page:
10
1 - 10 of 11